Showing results for Pediatrics
-
![Two men review results in a lab]()
IU researchers identify proteins fueling rare childhood leukemia, revealing new treatment strategy
By identifying a specific set of inflammatory proteins that drive JMML’s growth and weaken the immune system, IU researchers have uncovered a new strategy to ...
-
![Two researchers work in a lab]()
Scientists develop nanoparticle delivery system to target blood cancer cells
IU cancer researchers have developed a "smarter" nanoparticle delivery system that steers cancer therapies directly to multiple myeloma cells in the bone marrow while sparing ...
-
![A woman in a lab coat looks into a microscope]()
Beta cells may play active role in triggering Type 1 diabetes
Type 1 diabetes may be sparked by early failures in the stress responses of insulin-producing beta cells long before the immune system attacks.
-
![A doctor examines a child.]()
First pediatric patient in the world enrolled in PIONEER clinical trial for kidney glomerular disease at IU School of Medicine
Groundbreaking immunoglobulin A nephropathy research primarily focused on pediatric patients
-
![A man in a lab coat and tie poses for a headshot.]()
IU School of Medicine names national pediatric oncology leader as chair of pediatrics
Douglas K. Graham will lead the Department of Pediatrics beginning in August.
-
![A woman and child are photographed in Africa.]()
Severe childhood malaria linked to cognitive impairment later in life
Children who survived cerebral malaria and severe malarial anemia experienced cognitive impairment years after their initial illness.
-
![A woman in a white coat works in a lab.]()
IU researchers identify clotting protein as potential target in pancreatic cancer
Research published in Gastroenterology found a new possible way to slow pancreatic cancer spread.
-
![Two men work in a lab]()
Hidden blood mutations may be driving severe IBD — IU team uncovers new treatment target
IU researchers have linked an age-related blood condition to inflammatory bowel disease (IBD) and identified a potential treatment to reduce the severity of inflammation-driven diseases.
-
![A man and woman look at a lab object]()
IU School of Medicine’s 2025 NIH funding ranked No. 15 among public universities
The National Institutes of Health invested more than $230 million in the Indiana University School of Medicine during federal fiscal year 2024-25.
-
![A woman works in her lab]()
IU researchers uncover targetable weakness in hard-to-treat blood cancer
IU School of Medicine researchers have found that acute myeloid leukemia relies on an inflammation signal that can be targeted to weaken the treatment-resistant blood ...
.jpg?rev=f82b2bf1387a4d21a371a93c5f23b5a6&la=en&h=3197&w=4800&hash=1D2821498BCCFF44A9FDE8B0F9E53B64)
